Linked e-resources
Details
Table of Contents
Preface
PART I HEALTHCARE AND PHARMACEUTICALS: INNOVATION AND REGULATION IN JAPAN
Regulation and Competition in the Pharmaceutical Industry in Japan
Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population
Drug Regulation in Japan
Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan
Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies Gift-giving Practices
PART II THE JAPANESE ANTIMONOPOLY ACT AND ITS RELATION TO THE PHARMACEUTICAL INDUSTRY
Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan
Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act
Merger Regulations in the Japanese Pharmaceutical Industry
Pay-for-delay Agreements in Japan
No Challenge Clauses in the Pharmaceutical Industry in Japan
Will Authorised Biologics deter Biosimilars? -Utilising JFTCs expertise in drug pricing
PART III AN ECONOMIC ANALYSIS OF THE PHARMACEUTICAL INDUSTRY AND TRADE PRACTICES IN JAPAN
The Pharmaceutical Industry in Japan: A History of Its Development
Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.
PART I HEALTHCARE AND PHARMACEUTICALS: INNOVATION AND REGULATION IN JAPAN
Regulation and Competition in the Pharmaceutical Industry in Japan
Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population
Drug Regulation in Japan
Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan
Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies Gift-giving Practices
PART II THE JAPANESE ANTIMONOPOLY ACT AND ITS RELATION TO THE PHARMACEUTICAL INDUSTRY
Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan
Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act
Merger Regulations in the Japanese Pharmaceutical Industry
Pay-for-delay Agreements in Japan
No Challenge Clauses in the Pharmaceutical Industry in Japan
Will Authorised Biologics deter Biosimilars? -Utilising JFTCs expertise in drug pricing
PART III AN ECONOMIC ANALYSIS OF THE PHARMACEUTICAL INDUSTRY AND TRADE PRACTICES IN JAPAN
The Pharmaceutical Industry in Japan: A History of Its Development
Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.